A. Dimitrios Colevas

25.6k total citations · 2 hit papers
197 papers, 7.6k citations indexed

About

A. Dimitrios Colevas is a scholar working on Oncology, Otorhinolaryngology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, A. Dimitrios Colevas has authored 197 papers receiving a total of 7.6k indexed citations (citations by other indexed papers that have themselves been cited), including 111 papers in Oncology, 88 papers in Otorhinolaryngology and 54 papers in Pulmonary and Respiratory Medicine. Recurrent topics in A. Dimitrios Colevas's work include Head and Neck Cancer Studies (87 papers), Cancer Immunotherapy and Biomarkers (32 papers) and Lung Cancer Treatments and Mutations (25 papers). A. Dimitrios Colevas is often cited by papers focused on Head and Neck Cancer Studies (87 papers), Cancer Immunotherapy and Biomarkers (32 papers) and Lung Cancer Treatments and Mutations (25 papers). A. Dimitrios Colevas collaborates with scholars based in United States, Canada and France. A. Dimitrios Colevas's co-authors include Marshall R. Posner, Quynh‐Thu Le, Robert I. Haddad, Nynke S. van den Berg, Eben L. Rosenthal, Bonnie S. Glisson, Ann Setser, Ethan Basch, Andy Trotti and Vasu Divi and has published in prestigious journals such as Journal of Clinical Investigation, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

A. Dimitrios Colevas

190 papers receiving 7.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

E1308: Phase II Trial of Induction Chemotherapy Followed by Reduced-Dose Radiation and Weekly Cetuximab in Patients With HPV-Associated Resectable Squamous Cell Carcinoma of the Oropharynx— ECOG-ACRIN Cancer Research Group

2017 317 citations Shanthi Marur, Shuli Li et al. Journal of Clinical Oncology profile →
Proposal for the 8th edition of the AJCC/UICC staging system for nasopharyngeal cancer in the era of intensity‐modulated radiotherapy

2015 253 citations Brian O’Sullivan, Quynh‐Thu Le et al. profile →

Peers

Countries citing papers authored by A. Dimitrios Colevas

Since Specialization

Citations

This map shows the geographic impact of A. Dimitrios Colevas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Dimitrios Colevas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Dimitrios Colevas more than expected).

Fields of papers citing papers by A. Dimitrios Colevas

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Dimitrios Colevas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Dimitrios Colevas. The network helps show where A. Dimitrios Colevas may publish in the future.

Co-authorship network of co-authors of A. Dimitrios Colevas

This figure shows the co-authorship network connecting the top 25 collaborators of A. Dimitrios Colevas. A scholar is included among the top collaborators of A. Dimitrios Colevas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Dimitrios Colevas. A. Dimitrios Colevas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	First-in-Human Clinical Trial of a Small-Molecule EBNA1 Inhibitor, VK-2019, in Patients with Epstein-Barr–Positive Nasopharyngeal Cancer, with Pharmacokinetic and Pharmacodynamic Studies 2025 ·Clinical Cancer Research ·A. Dimitrios Colevas, Zahra Talebi, (unknown), (unknown), Victor Lee, Maura L. Gillison, Saad A. Khan, Rong Lü, Benjamin A. Pinsky, Samantha S. Soldan, (unknown), Paul M. Lieberman, Troy E. Messick	4
2	Platinum/taxane/pembrolizumab vs platinum/5FU/pembrolizumab in recurrent/metastatic head and neck squamous cell carcinoma (r/m HNSCC) 2024 ·Oral Oncology ·Lova Sun, Roger B. Cohen, A. Dimitrios Colevas	4
3	Nasopharyngeal cancer mortality in disaggregated Asian and non‐Asian Americans 2024 ·Head & Neck ·George Hung, (unknown), Gina Kim, Armaan Jamal, Malathi Srinivasan, Robert J. Huang, Gloria Kim, Latha Palaniappan, A. Dimitrios Colevas	1
4	Automated patient selection and care coaches to increase advance care planning for patients with cancer 2024 ·JNCI Journal of the National Cancer Institute ·Michael F. Gensheimer, Winifred Teuteberg, Manali I. Patel, Divya Gupta, (unknown), (unknown), (unknown), (unknown), Ying Lü, (unknown), (unknown), (unknown), Jan C. DeNofrio, (unknown), Nigam H. Shah, Tai C. Chen, Elwyn C. Cabebe, Douglas W. Blayney, A. Dimitrios Colevas, Kavitha Ramchandran	3
5	Validation of a robust and rapid liquid chromatography tandem mass spectrometric method for the quantitative analysis of VK‐2019, a selective EBNA1 inhibitor 2023 ·Biomedical Chromatography ·Michael T. Davis, Nicole M. Anders, A. Dimitrios Colevas, Troy E. Messick, Michelle A. Rudek	4
6	89Zr-panitumumab Combined With 18F-FDG PET Improves Detection and Staging of Head and Neck Squamous Cell Carcinoma 2022 ·Clinical Cancer Research ·Y.-J. Lee, Nynke S. van den Berg, Heying Duan, (unknown), Valentina Ferri, (unknown), (unknown), (unknown), (unknown), (unknown), Quan Zhou, Laura E. Beane Freeman, Mary Ellen I. Koran, Michael J. Kaplan, A. Dimitrios Colevas, Fred M. Baik, Frederick T. Chin, Brock A. Martin, Andrei Iagaru, Eben L. Rosenthal	10
7	Do Steroids Matter? A Retrospective Review of Premedication for Taxane Chemotherapy and Hypersensitivity Reactions 2021 ·Journal of Clinical Oncology ·Olivia Lansinger, (unknown), Zihuai He, A. Dimitrios Colevas	22
8	Unambiguous advanced radiologic extranodal extension determined by MRI predicts worse outcomes in nasopharyngeal carcinoma: Potential improvement for future editions of N category systems 2021 ·Radiotherapy and Oncology ·Yan‐Ping Mao, Shunxin Wang, William M. Lydiatt, Jatin P. Shah, A. Dimitrios Colevas, Anne W.M. Lee, Brian O’Sullivan, Rui Guo, Wei‐Jie Luo, Yu‐Pei Chen, Li Tian, Ling‐Long Tang, Ying Sun, Lizhi Liu, Jian Ren, Jun Ma	41
9	Predicting Therapeutic Antibody Delivery into Human Head and Neck Cancers 2020 ·Clinical Cancer Research ·Guolan Lu, Shayan Fakurnejad, Brock A. Martin, Nynke S. van den Berg, Stan van Keulen, Naoki Nishio, (unknown), Stefania U. Chirita, Quan Zhou, Rebecca W. Gao, Christina S. Kong, Nancy J. Fischbein, (unknown), A. Dimitrios Colevas, Eben L. Rosenthal	37
10	The Sentinel Margin: Intraoperative Ex Vivo Specimen Mapping Using Relative Fluorescence Intensity 2019 ·Clinical Cancer Research ·Stan van Keulen, Naoki Nishio, Andrew C. Birkeland, Shayan Fakurnejad, Brock A. Martin, Tymour Forouzanfar, Kristen Cunanan, A. Dimitrios Colevas, Nynke S. van den Berg, Eben L. Rosenthal	55
11	Nivolumab in Patients with Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck: Efficacy and Safety in CheckMate 141 by Prior Cetuximab Use 2019 ·Clinical Cancer Research ·Robert L. Ferris, Lisa Licitra, Jérôme Fayette, Caroline Even, George R. Blumenschein, Kevin J. Harrington, J. Guigay, Everett E. Vokes, Nabil F. Saba, Robert I. Haddad, S. Ramkumar, Jeffery S. Russell, Peter Brossart, Makoto Tahara, A. Dimitrios Colevas, Fernando Concha‐Benavente, Mark Lynch, Li Li, Maura L. Gillison	115
12	Determination of Tumor Margins with Surgical Specimen Mapping Using Near-Infrared Fluorescence 2018 ·Cancer Research ·Rebecca W. Gao, Nutte Teraphongphom, Nynke S. van den Berg, Brock A. Martin, Nicholas J. Oberhelman, Vasu Divi, Michael J. Kaplan, Steven Hong, Guolan Lu, Robert Ertsey, Willemieke S. Tummers, Adam J. Gomez, F. Christopher Holsinger, Christina S. Kong, A. Dimitrios Colevas, Jason M. Warram, Eben L. Rosenthal	160
13	Pembrolizumab for advanced basal cell carcinoma: An investigator-initiated, proof-of-concept study 2018 ·Journal of the American Academy of Dermatology ·Anne Lynn S. Chang, Duy Tran, (unknown), Shufeng Li, (unknown), Roma Patel, (unknown), (unknown), (unknown), Kerri E. Rieger, Ansuman T. Satpathy, Kathryn E. Yost, Sunil Reddy, Kavita Y. Sarin, A. Dimitrios Colevas	78
14	E1308: Phase II Trial of Induction Chemotherapy Followed by Reduced-Dose Radiation and Weekly Cetuximab in Patients With HPV-Associated Resectable Squamous Cell Carcinoma of the Oropharynx— ECOG-ACRIN Cancer Research Group breakdown → 2017 ·Journal of Clinical Oncology ·Shanthi Marur, Shuli Li, Anthony J. Cmelak, Maura L. Gillison, Weiqiang Zhao, Robert L. Ferris, William H. Westra, Jill Gilbert, Julie E. Bauman, Lynne I. Wagner, David R. Trevarthen, (unknown), Barbara A. Murphy, Nishant Agrawal, A. Dimitrios Colevas, Christine H. Chung, Barbara Burtness	317
15	Long-Term Safety and Clinical Outcomes of Atezolizumab in Head and Neck Cancer: Phase Ia Trial Results 2017 ·Annals of Oncology ·Rastislav Bahleda, Fadi S. Braiteh, Ani Sarkis Balmanoukian, Irene Braña, F. Stephen Hodi, Lawrence Garbo, (unknown), Luciana Molinero, Carol O’Hear, Xiaoyan Shen, A. Dimitrios Colevas	21
16	Effects of Combined Treatment With Arsenic Trioxide and Itraconazole in Patients With Refractory Metastatic Basal Cell Carcinoma 2016 ·JAMA Dermatology ·Mina S. Ally, Katherine J. Ransohoff, Kavita Y. Sarin, Scott X. Atwood, Melika Rezaee, Irene Bailey, Juyong Brian Kim, Philip A. Beachy, Anne Lynn S. Chang, Anthony E. Oro, Jean Y. Tang, A. Dimitrios Colevas	75
17	Higher incidence of head and neck cancers among Vietnamese American men in California 2010 ·Head & Neck ·Édith Filion, Laura A. McClure, (unknown), (unknown), Michael J. Kaplan, A. Dimitrios Colevas, Scarlett Lin Gomez, Ellen T. Chang, Quynh‐Thu Le	9
18	Long-Term Outcomes and Toxicity of Concurrent Paclitaxel and Radiotherapy for Locally Advanced Head-and-Neck Cancer 2008 ·International Journal of Radiation OncologyBiologyPhysics ·Deborah E. Citrin, (unknown), Anna Likhacheva, Linda Sciuto, Paul S. Albert, Susan F. Rudy, (unknown), Ana P. Cotrim, Beth Solomon, A. Dimitrios Colevas, Angelo Russo, John C. Morris, Laurie L. Herscher, Sharon L. Smith, Carter Van Waes	38
19	HER2 Expression in Salivary Gland Carcinomas 2004 ·Clinical Cancer Research ·Bonnie S. Glisson, A. Dimitrios Colevas, Robert I. Haddad, (unknown), Adel K. El‐Naggar, Merrill S. Kies, Rosemary Costello, (unknown), Matthew A. Arquette, Corey J. Langer, Philip C. Amrein, Marshall R. Posner	158
20	Phase I/II Trial of Outpatient Docetaxel, Cisplatin, 5-Fluorouracil, Leucovorin (opTPFL) as Induction for Squamous Cell Carcinoma of the Head and Neck (SCCHN) 2002 ·American Journal of Clinical Oncology ·A. Dimitrios Colevas, Charles M. Norris, Roy B. Tishler, Carolyn C. Lamb, Marvin P. Fried, Laura A. Goguen, Harsha Gopal, Régis Costello, (unknown), S. Adak, Marshall R. Posner	43

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact